Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumor × Valproic Acid × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3 Brain Neoplasms 3 Glioma 2 Thyroid Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Neurologic Manifestations 1 Neoplasms, Neuroepithelial 1 Neoplasm Metastasis 1 Lymphoma 1 Leukemia 1 Head and Neck Neoplasms 1 HTLV-I Infections 1 Gliosarcoma 1 Diffuse Intrinsic Pontine Glioma 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

pertuzumab 2 durvalumab 2 Paclitaxel 2 Nivolumab 2 Docetaxel 2 Capecitabine 2 ulocuplumab 1 tremelimumab 1 tazarotene 1 talazoparib 1 romiplostim 1 pexidartinib 1 pembrolizumab 1 pamiparib 1 magrolimab 1 entrectinib 1 cobimetinib 1 atezolizumab 1 Sunitinib 1 Rifampin 1 Radiosurgery 1 Midazolam 1 LY3022855 1 LY2510924 1 Itraconazole 1 Irinotecan 1 Ipilimumab 1 Dextromethorphan 1 Carboplatin 1 CH5183284 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡